Drug Development Archives

Publication

Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results

Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…

CertaraOctober 15, 2025

Webinar

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

US (ET): Thursday, November 6, 11:00am – 11:30am EMEA (GMT): Thursday, November 13, 10:00am –…

Danielle PillsburyOctober 10, 2025

Webinar

RAPS Sponsored Webinar: Planning and Preparing Regulatory Submissions Using Top-down Messaging

CertaraOctober 9, 2025

Conference

ICAComP 2025

CertaraOctober 8, 2025

Conference

Dutch Medicines Days

CertaraOctober 7, 2025

Case Study

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…

CertaraOctober 2, 2025

Conference

37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT)

CertaraSeptember 22, 2025

Announcement

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage…

CertaraSeptember 22, 2025

Announcement

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

RADNOR, Pa. – September 17, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraSeptember 17, 2025

Blog

FAQs on Developing EMA Policy 0070 Submissions

This blog answers audience questions posed during our RAPS webinar, How to Plan for a…

CertaraSeptember 15, 2025

Drug Development

Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

RAPS Sponsored Webinar: Planning and Preparing Regulatory Submissions Using Top-down Messaging

ICAComP 2025

Dutch Medicines Days

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT)

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

FAQs on Developing EMA Policy 0070 Submissions

Newsletter sign up

Quick links

Solutions

Contact